JRCT ID: jRCT2080220408
Registered date:21/06/2007
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Perennial allergic rhinitis |
Date of first enrollment | 21/06/2007 |
Target sample size | 236 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Cetirizine INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Change in the total nasal symptom score, safety, etc. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 2age old |
---|---|
Age maximum | <= 14age old |
Gender | |
Include criteria | Age:2 to 14, Children with perennial allergic rhinitis, Patients eligible for evaluation of nasal symptom, etc |
Exclude criteria |
Related Information
Primary Sponsor | GlaxoSmithKline K.K. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-070417 |
Contact
Public contact | |
Name | |
Address | http://glaxosmithkline.co.jp/contact.html |
Telephone | |
Affiliation | GlaxoSmithKline K.K. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |